Status:
COMPLETED
AUGMENTIN 1gm In Skin And Soft Tissue Infection
Lead Sponsor:
GlaxoSmithKline
Conditions:
Skin Diseases, Infectious
Infection, Soft Tissue
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections
Eligibility Criteria
Inclusion
- having diagnosed uncomplicated soft tissue infection (e.g furuncle, cellulitis)
- has given freely documented consent.
Exclusion
- antibiotics
- have renal or hepatic insufficiency
- systemic toxicity
- pregnancy
- lactation
- hypersensitivity to penicillin or Beta-lactam antibiotics
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT00343135
Start Date
December 1 2004
End Date
March 1 2005
Last Update
November 22 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Karachi, Pakistan
2
GSK Investigational Site
Lahore, Pakistan, 54000
3
GSK Investigational Site
Lahore, Pakistan